Details werden geladen...
Investigational daily pill doubles survival in metastatic pancreatic cancer, study shows | UCLA
Targeted therapy with the drug daraxonrasib significantly improves survival and tumor response compared with chemotherapy.
Ähnliche Seiten
Daily pill almost doubles survival time for pancreatic cancer patients in new trial | The Independent
https://www.independent.co.uk/news/health/pancreatic-cancer-symptoms-pill-daraxonrasib-b2986710.html
How a daily pill doubles pancreatic cancer survival time
https://inews.co.uk/shorts/how-a-daily-pill-doubles-pancreatic-cancer-survival-time
Pancreatic cancer pill doubles survival time compared to chemotherapy: study – CTVNews
https://www.ctvnews.ca/video/2026/06/02/pancreatic-cancer-pill-doubles-survival-time-compared-to-chemotherapy-study/
Breakthrough drug nearly doubles survival rate for advanced pancreatic cancer
https://refractor.io/cancer/breakthrough-drug-doubles-survival-pancreatic-cancer/
Experimental pill offers breakthrough hope in pancreatic cancer fight | Daily Sabah
https://www.dailysabah.com/life/health/experimental-pill-offers-breakthrough-hope-in-pancreatic-cancer-fight